Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers

Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome

(2011) R. Yerushalmi et al.   ANNALS OF ONCOLOGY

Evaluation of tumor markers (HER-2/neu oncoprotein, CEA, and CA 15.3) in patients with locoregional breast cancer: prognostic value

(2010) Rafael Molina et al.   TUMOR BIOLOGY

Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer

(2009) Hyo Song Kim et al.   BREAST CANCER RESEARCH AND TREATMENT

Serum tumour markers: how to order and interpret them

(2009) C M Sturgeon et al.   BMJ-British Medical Journal

Prognostic factors in 1038 women with metastatic breast cancer

(2008) R. Largillier et al.   ANNALS OF ONCOLOGY

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Clinical Practice: Quality Requirements

(2008) C. M. Sturgeon et al.   CLINICAL CHEMISTRY